T2D Research

T2D T-Cell Immunometabolic Subtypes × T2D Transcription Factor Activity

Properties2
tagssynthesis, type-2-diabetes, pbmc, immunology, transcriptomics
aliasesT2D T-Cell Immunometabolic Subtypes × T2D Transcription Factor Activity

3 min read

T2D T-Cell Immunometabolic Subtypes × T2D Transcription Factor Activity

The Connection

Li et al. 2025 first stratified T2D samples into T-cell metabolic subtypes A-C based on GSVA pathway scores, then profiled transcription-factor activity across those same subtypes using DoRothEA/VIPER. These are not independent findings — the TF activity patterns are subtype-specific because the subtypes themselves define the sample groupings. The manuscript-safe interpretation is that Li layers metabolic GSVA scores and inferred TF regulon activity within the same subtype groupings; causal direction from metabolism to TF activity is not tested.

Where They Co-occur

Both concepts are derived from Li et al. and co-occur in the single-cell PBMC profiling page, the T2D cytotoxic T-cell expansion page, the drug enrichment page, the project page, and the Li et al. reference page. Their 5 co-occurring pages reflect their shared origin and the paper’s interest in connecting metabolic heterogeneity to transcriptional regulation mechanisms.

Cross-cutting Insight

The link between metabolic subtype and TF activity suggests that T2D immune dysregulation may span multiple expression-derived regulatory layers. Each subtype follows a distinct inferred pattern:

  • Subtype A shows higher lipid and xenobiotic metabolism scores alongside inferred EPAS1 regulon activity in memory and cytotoxic CD8+ T cells. EPAS1 is a hypoxia-inducible factor, so this is consistent with a metabolic-stress/transcriptional-adaptation hypothesis.
  • Subtype B shows inferred NFKB1 regulon activity in regulatory CD4+ T cells. In this cell context, NFKB1 activity may reflect inflammatory or regulatory-state signaling depending on target genes and phenotype.
  • Subtype C shows inferred T-cell-differentiation TF activity (BCL11A, TBX21, IKZF1) alongside reduced memory and naive CD8+ T-cell proportions, consistent with a more differentiated or effector-biased T-cell-state hypothesis.

Together these patterns suggest that T2D immune heterogeneity may involve coordinated metabolic pathway scores, immune-cell composition, and inferred regulon activity. They do not establish that metabolic changes propagate upward through a regulatory network.

Tensions and Trade-offs

  • The TF activity inferences are computational (DoRothEA/VIPER), not direct measurements — they reflect regulon expression coherence rather than confirmed protein activity or DNA binding.
  • Because both subtype definition and TF profiling use the same single-cell data, the metabolic → TF causal direction is assumed rather than tested. TF activity could alternatively drive metabolic gene expression.
  • The subtype sample sizes (reported as 12-14 T2D patients per group) limit the statistical resolution for TF comparisons across subtypes and should be source-checked before quantitative manuscript claims.
  • For manuscript use, this synthesis provides mechanistic plausibility for linking immunometabolic heterogeneity to transcriptional regulation, but should be framed as hypotheses from computational inference rather than established mechanisms.

Open Questions

  • Would the same TF activity patterns emerge if subtypes were defined on an independent cohort using the same GSVA + consensus clustering approach?
  • Do any of the identified TF regulons (EPAS1, NFKB1, TBX21, BCL11A) show ancestry-associated variation in the project’s own data?
  • Can the subtype-specific TF activity patterns be linked to chromatin accessibility differences in the project’s scATAC-seq data?

Graph View

Backlinks